BAM
NH

Brave Asset Management’s NantHealth, Inc NH Stock Holding History

Brave Asset Management’s Portfolio NH Stock Details NH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-7
Closed -$1K – 350
2016
Q3 		$1K Hold
7
– – ﹤0.01% 380
2016
Q2 		$1K Buy
+7
New +$1.52K ﹤0.01% 391

Other funds holding NH

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brave Asset Management's NH Position: Q4 2016 in Review

Brave Asset Management sold out of NantHealth, Inc (NH) in Q4 2016, closing a stake of 7 shares — an estimated $1K sold.

Brave Asset Management first reported a position in NH in Q2 2016 and held it in 2 quarters. The position peaked at $1K in Q3 2016. 44 funds tracked by Wall St. Rank hold NH as of Q4 2016.

  • Brave Asset Management reported no remaining NantHealth, Inc position as of Q4 2016 after selling out during the quarter.
  • Brave Asset Management sold 7 NantHealth, Inc shares in Q4 2016, an estimated $1K.
  • Brave Asset Management first reported a position in NantHealth, Inc in Q2 2016 and held it in 2 quarters.
  • Brave Asset Management's NantHealth, Inc position peaked at $1K in Q3 2016.
  • 44 funds tracked by Wall St. Rank held NantHealth, Inc as of Q4 2016.

Based on Brave Asset Management's 13F filing for Q4 2016, filed 27 Jan 2017.